Abstract:Graphical and Lay Summary 22(R)‐Hydroxycholesterol (22(R)‐HCHO) is a key precursor of steroids biosynthesis with various biological functions. However, the production of 22(R)‐HCHO is expensive and unsustainable by chemical synthesis and extraction from plants or animals. In this study, the authors demonstrate the efficient biosynthesis of 22(R)‐HCHO in yeast through systematic metabolic engineering, including identification of efficient Dhcr7 and cholesterol 22‐hydroxylase, regulation of key genes expression, and hybrid diploids to balance strain growth and 22(R)‐HCHO production. Finally, the strain 22HC15 produced 2.03 g/L 22(R)‐HCHO in a 5‐L fermenter, which represents the highest 22(R)‐HCHO titer reported to date. The results of this study provide a foundation for further applications of 22(R)‐HCHO in various industrially valuable steroids. 22(R)‐hydroxycholesterol (22(R)‐HCHO) is a crucial precursor of steroids biosynthesis with various biological functions. However, the production of 22(R)‐HCHO is expensive and unsustainable due to chemical synthesis and extraction from plants or animals. This study aimed to construct a microbial cell factory to efficiently produce 22(R)‐HCHO through systems metabolic engineering. First, we tested 7‐dehydrocholesterol reductase (Dhcr7s) and cholesterol C22‐hydroxylases from different sources in Saccharomyces cerevisiae, and the titer of 22(R)‐HCHO reached 128.30 mg L−1 in the engineered strain expressing Dhcr7 from Columba livia (ClDhcr7) and cholesterol 22‐hydroxylase from Veratrum californicum (VcCyp90b27). Subsequently, the 22(R)‐HCHO titer was significantly increased to 427.78 mg L−1 by optimizing the critical genes involved in 22(R)‐HCHO biosynthesis. Furthermore, hybrid diploids were constructed to balance cell growth and 22(R)‐HCHO production and to improve stress tolerance. Finally, the engineered strain produced 2.03 g L−1 of 22(R)‐HCHO in a 5‐L fermenter, representing the highest 22(R)‐HCHO titer reported to date in engineered microbial cell factories. The results of this study provide a foundation for further applications of 22(R)‐HCHO in various industrially valuable steroids.

Engineered yeast for efficient de novo synthesis of 7‐dehydrocholesterol

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

Engineering sub-organelles of a diploid Saccharomyces cerevisiae to enhance the production of 7-dehydrocholesterol

Secretory production of 7-dehydrocholesterol by engineered Saccharomyces cerevisiae

Reengineering of 7-dehydrocholesterol biosynthesis in Saccharomyces cerevisiae using combined pathway and organelle strategies

Metabolic Engineering of Saccharomyces Cerevisiae for 7-Dehydrocholesterol Overproduction.

Efficient production of 22(R)‐hydroxycholesterol via combination optimization of Saccharomyces cerevisiae

Alleviating Redox Imbalance Enhances 7-Dehydrocholesterol Production in Engineered Saccharomyces Cerevisiae.

Compartmentalized Reconstitution of Post-squalene Pathway for 7-Dehydrocholesterol Overproduction in Saccharomyces cerevisiae

Engineering of Saccharomyces cerevisiae for 24-Methylene-Cholesterol Production

Selective Biosynthesis of Retinol in S. Cerevisiae.

Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae.

Enhanced Astaxanthin Production in S. Cerevisiae by Combinatorial Engineering of Gene Targets Outside the Synthetic Pathway

Match of functional module with chassis in 7-dehydrocholesterol synthesis

Production of Retinoic Acid by Engineered Saccharomyces Cerevisiae Using an Endogenous Aldehyde Dehydrogenase.

Systematic metabolic engineering enables highly efficient production of vitamin A in Saccharomyces cerevisiae

Biosynthesis and Engineering of Kaempferol in Saccharomyces Cerevisiae

Multi‐modular engineering of Saccharomyces cerevisiae for high‐titre production of tyrosol and salidroside

Multi-modular engineering of<i>Saccharomyces cerevisiae</i>for high-titre production of tyrosol and salidroside

De Novo Production of Hydroxytyrosol by Metabolic Engineering of Saccharomyces cerevisiae

Establishment of Saccharomyces cerevisiae as a cell factory for efficient de novo production of monogalactosyldiacylglycerol